In this article, we explain everything you need to know about the Functional Assessment of Cancer Therapy-General (FACT-G). We will cover the aspects it evaluates, the target population, a detailed step-by-step explanation, and how to interpret its results. Additionally, we will dive into the scientific evidence supporting this tool (diagnostic sensitivity and specificity) in clinical assessment. You will also find official and unofficial sources available for download in PDF format.
What does the Functional Assessment of Cancer Therapy-General (FACT-G) assess?
The Functional Assessment of Cancer Therapy-General (FACT-G) is a validated instrument designed to evaluate the quality of life in patients undergoing treatment for cancer. It assesses multiple domains including physical well-being, social/family well-being, emotional well-being, and functional well-being, providing a comprehensive overview of the patient’s health status. The main purpose of the FACT-G is to measure the impact of disease and treatment on daily functioning and overall quality of life, facilitating clinical decision-making and research in oncology settings. By capturing patient-reported outcomes, this tool aids healthcare providers in tailoring interventions to improve supportive care and manage symptoms effectively.
For which type of patients or populations is the Functional Assessment of Cancer Therapy-General (FACT-G) intended?
The Functional Assessment of Cancer Therapy-General (FACT-G) is indicated primarily for patients diagnosed with a variety of solid tumors and hematologic malignancies. It is most useful in assessing health-related quality of life (HRQoL) during clinical trials, routine oncologic care, and longitudinal studies monitoring treatment impact. This instrument captures multidimensional aspects of well-being, including physical, social, emotional, and functional domains, providing valuable insights for healthcare professionals managing patients undergoing chemotherapy, radiotherapy, or targeted therapies. Its standardized format facilitates comparison across different cancer populations and treatment modalities, ensuring an objective evaluation of patient-reported outcomes.
Step-by-Step Explanation of the Functional Assessment of Cancer Therapy-General (FACT-G)
The Functional Assessment of Cancer Therapy-General (FACT-G) consists of 27 items designed to measure four quality-of-life domains: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, and Functional Well-Being. Each item is a statement related to symptoms, functionality, or emotional status typically experienced by patients with cancer. Respondents rate items on a 5-point Likert scale ranging from 0 (“Not at all”) to 4 (“Very much”), reflecting the extent to which each statement applied over the past 7 days. Administration begins by instructing the patient to consider their recent experiences and answer all items honestly. Scores are computed by summing responses within each domain and can be combined to form a total score indicating overall health-related quality of life. This standardized methodology ensures consistency across clinical and research settings, facilitating reliable assessment of patient-reported outcomes in oncology care.
Functional Assessment of Cancer Therapy-General (FACT-G) PDF Resources for Cancer Quality of Life
Downloadable resources for the Functional Assessment of Cancer Therapy-General (FACT-G) are available below, provided in both the original language and an English translation. These materials are offered in PDF format to facilitate ease of access and consistent use in clinical and research settings. The FACT-G is a validated instrument widely utilized to assess the quality of life in patients undergoing treatment for various cancers, ensuring comprehensive evaluation across multiple health domains.
How to interpret the results of the Functional Assessment of Cancer Therapy-General (FACT-G)?
The Functional Assessment of Cancer Therapy-General (FACT-G) score ranges from 0 to 108, with higher scores indicative of better health-related quality of life across four domains: physical, social/family, emotional, and functional well-being. Healthcare professionals interpret individual domain and total scores by comparing them to established normative reference values, typically stratified by cancer type and stage, to assess patient status accurately. For example, a total score below 70 may signal significant impairment, warranting targeted interventions. The calculation involves summing domain scores: FACT-G Total Score = Physical + Social/Family + Emotional + Functional scores. In clinical practice, these results guide treatment planning by identifying areas needing supportive care, monitoring therapeutic efficacy, and predicting overall patient prognosis in conditions such as breast cancer or lung cancer. Understanding these results enables providers to tailor interventions to improve patient-centered outcomes effectively.
What scientific evidence supports the Functional Assessment of Cancer Therapy-General (FACT-G) ?
The Functional Assessment of Cancer Therapy-General (FACT-G) test was developed in the 1990s by Cella et al. to provide a reliable measure of health-related quality of life in patients with various cancer types. Its validity has been extensively established through rigorous psychometric evaluations, including assessments of internal consistency, test-retest reliability, and construct validity across diverse oncological populations. Numerous studies have demonstrated that the FACT-G effectively captures multidimensional domains such as physical, social/family, emotional, and functional well-being, facilitating comprehensive patient-centered outcome measurement. The instrument’s sensitivity to clinical changes and its correlation with other established quality of life scales further underscore its scientific robustness. Validation efforts continue to support its utility in both clinical trials and routine oncology practice, making it a standard tool for assessing treatment impact on patients with malignancies including breast, lung, and prostate cancer.
Diagnostic Accuracy: Sensitivity and Specificity of the Functional Assessment of Cancer Therapy-General (FACT-G)
The Functional Assessment of Cancer Therapy-General (FACT-G) is primarily designed as a quality of life measurement tool rather than a diagnostic test; therefore, traditional metrics such as sensitivity and specificity are not typically reported for this instrument. Instead, its validity is established through reliability coefficients and construct validity assessments across various cancer populations. Studies have demonstrated high internal consistency with Cronbach’s alpha values generally exceeding 0.85, indicating robust reliability. While FACT-G effectively discriminates between different levels of patient well-being and correlates strongly with clinical indicators of disease progression and treatment side effects, it is not used as a screening test, so sensitivity and specificity data are not applicable or available in the literature.
Related Scales or Questionnaires
The Functional Assessment of Cancer Therapy-General (FACT-G) shares similarities with several other validated instruments, such as the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the Medical Outcomes Study Short Form-36 (SF-36). The EORTC QLQ-C30 is widely used in oncology trials and offers comprehensive coverage of symptoms and functioning, though its length can be burdensome for patients. The SF-36 provides a broad assessment of general health status suitable for various chronic diseases, but it lacks cancer-specific domains, limiting sensitivity in cancer-related quality of life measurements. Both scales, along with others like the MD Anderson Symptom Inventory (MDASI), are explained in detail and available for download on ClinicalToolsLibrary.com. These instruments vary in focus and respondent burden, enabling clinicians to select tools aligned with specific research or clinical objectives in managing cancer and related comorbidities.
